CMS
ICD-9-CM Annual Update
The annual update of the International Classification of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) will occur effective October 1, 2003. An ICD-9-CM code is required on all paper and electronic
claims billed to Medicare carriers with the exception of ambulance claims (specialty type 59) effective
October 1, 2003. Medicare carriers will accept both the old and new ICD-9-CM codes for dates of service
October 1, 2003, through December 31, 2003.
The CMS website www.cms.hhs.gov/medlearn/icd9code.asp
contains the new, revised, and deleted ICD-9-CM codes that are effective for dates of service on or after
October 1, 2003. You are encouraged to visit the National Center for Health Statistics (NCHS) website at
www.cdc.gov/nchs/icd9.htm. You may purchase
ICD-9-CM books from technical bookstores or technical publishing companies.
Reference: CMS Program Memorandum Change Request 2763; Transmittal AB-03-091
See the complete transmittal on the CMS website at
http://cms.hhs.gov/manuals/pm_trans/AB03091.pdf
New Tracking Sheet
CMS has posted a new tracking sheet to re-evaluate the inclusion of ICD-9-CM codes 584, 585 and 586 (acute
renal failure,chronic renal failure and renal failure unspecified) in the Urine Culture Bacterial NCD. Public
comment date is 8/7/2003. Urine Culture Bacterial (Re-evaluation of Inclusion of Renal Failure in the List of
ICD-9-CM Codes Covered) New tracking sheet
announcing review of lab NCD.
Changes to the Laboratory NCD Edit Software
October 1, 2003
Effective October 1, 2003, changes to the edit software for clinical diagnostic laboratory National Coverage
Determinations (NCDs) will be implemented to include the new ICD-9-CM codes which are updated annually.
New ICD-9-CM codes can render some of the presently covered codes inappropriate. Most commonly, codes are
expanded so that additional digits are necessary. For example, a code that presently is displayed as 4 digits
may be expanded to require 5 digits. The coding changes below are considered ministerial in that existing codes
within the NCD are replaced with the more current code structure or adding new codes that are within an
existing covered range. Since CMS provides a 90 day grace period for the existing codes, both the existing
and current ICD-9 codes will be accepted. Effective January 1, 2004, only the current ICD-9 codes will be
accepted.
The following ICD-9 changes will be made to the lab NCD edit software for services furnished on or after
October 1, 2003.
NCD List of Covered Dx |
Old Dx Codes |
New Dx |
Added Dx Codes |
Serum Iron Studies
|
282.4 |
282.41, 282.42 and 282.49 |
282.64, 282.68 and 289.52
|
V43.2 |
V43.21 and V43.22 |
Urine Culture Bacterial
| 600 |
600.00 and 600.01 |
780.93, 780.94, 785.52 and 788.63
|
600.1 |
600.10 and 600.11 |
600.2 |
600.20 and 600.21 |
600.9 |
600.90 and 600.91 |
Human Immunodeficiency Virus Testing (Diagnosis)
| 348.3 |
348.30 and 348.39 |
331.19
|
530.2 |
530.20, 530.21 and 530.82 |
Partial Thromboplastin Time |
767.1 |
767.11 |
|
Prothrombin Time |
767.1 |
767.11 |
414.07 |
V43.2 |
V43.21 and V43.22 |
Collagen Cross-links |
|
|
V58.65 |
Blood Glucose
|
790.2 |
790.21, 790.22 and 790.29 |
414.07, V58.63, V58.64 and V58.65
|
348.3 |
348.31 |
Glycated Hemoglobin |
790.2 |
790.21, 790.22 and 790.29 |
|
Thyroid Testing |
331.1 |
331.11 and 331.19 |
728.87, 780.93 and 780.94 |
Lipid Testing |
|
|
401.1, 414.07, V58.63 and V58.64 |
Prostate Specific Antigen |
|
|
788.63 |
Gamma Glutamyl Transferase |
|
|
282.64, 282.68, 289.52, V58.63 and V58.64 |
Fecal Occult Blood |
530.2 |
530.20, 530.21 and 530.85 |
V58.63, V58.64 and V58.65 |
|
|
|
|
NCD List of Covered Dx that Do Not Support Medical Necessity |
Old Dx Codes |
New Dx |
Added Dx Codes |
Blood Counts
| 600 |
600.00 and 600.01 |
799.81, V25.03, V45.85 and 788.63 |
600.1 |
600.10 and 600.11 |
600.2 |
600.20 and 600.21 |
600.9 |
600.90 and 600.91 |
V04.8 |
V04.81, V04.82 and V04.89 |
V53.9 |
V53.90, V53.91 and V53.99 |
V54.0 |
V54.01, V54.02 and V54.09 |
|
|
|
|
NCD List of Denial Dx |
Old Dx Codes |
New Dx |
Added Dx Codes |
Applicable to all 23 NCDs |
V65.1 |
V65.11 and V65.19 |
|
For more information on Lab NCDs, please see CMS website: http://cms.hhs.gov/ncdr.
Reference: CMS Program Memorandum Change Request 2814; Transmittal
AB-03-104.
OIG
The OIG has released a final inspection report that found that over half of providers in the active Unique
Physician/Practitioner Identification Number (UPIN) database had at least one practice setting record with
inaccurate information. CMS intends to use data in the UPIN Registry to enumerate the National Provider System.
However, if inaccurate data are used to populate the system, the new identifiers will not meet their full
potential as a protection for the Medicare program and the people it serves. OIG recommends that CMS correct
inaccurate and incomplete information in the UPIN Registry and deactivate practice settings that are not used.
CMS concurred with the recommendations.
Arkansas Medicare Services
Urinalysis, AC-02-015
Policy was revised to allow diagnosis codes 639.0, 639.3, 639.8, 643.0, 643.10, 643.11, 643.13, 648.00-648.04,
648.80-648.84 and V28.8 (CPTs 81000, 81001, 81002, 81003, 81005, 81007 and 81015) which correlate with "Indications
and Limitations" item 8 relating to pregnant patients. This is an expansion of policy and effective retroactively
back to date of service August 15, 2002.
HER2 TESTING, AC-99-515
Added Vysis PathVysion HER2 DNA Probe (CPTs 83950, 88271 and 88342) to the list of FDA approved tests in the
"Description" and "I&L" effective with the FDA approved date of 08/28/2002.
Reference:
http://www.arkmedicare.com/provider/mrdpolb/polmanindex1.asp
Missouri Medicare Services
HER2 Testing, AC-99-515
The Vysis PathVysion HRT2 DNA Probe (CPTs 83950, 88271 and 88342) has been added to the list of allowable
tests that determine overexpression of HER2. This is effective with date of service August 28, 2002 as per
the FDA approval letter.
Urinalysis, AC-02-015
Policy was revised to allow diagnosis codes 639.0, 639.3, 639.8, 643.0, 643.10, 643.11, 643.13, 648.00-648.04,
648.80-648.84 and V28.8 (CPTs 81000, 81001, 81002, 81003, 81005, 81007 and 81015) which correlate with "Indications
and Limitations" item 8 relating to pregnant patients. This is an expansion of policy and effective retroactively
back to date of service August 15, 2002.
Reference:
http://www.momedicare.com/provider/medpol/polmanindex1.asp
New York (Empire Medicare)
Prostate Specific Antigen, LB012E00
Coordinated LMRP for Empire New Jersey and New York. Incorporated NCD information on Total PSA into LMRP.
Added information on complexed PSA. CPTs G0103, 84152, 84153 and 84154.
B-Type Natriuretic Peptide (BNP), LB10E00
Added LMRP for CPT 83880.
Human Immunodeficiency Virus Testing (Prognosis Including Monitoring), LB011E00
Added LMRP for CPTs 87536 and 87539.
Viral Hepatitis Serology Tests, LB013E00
This policy revision complements the Medicare National Coverage Decision on Acute Hepatitis Panel (CPTs 86705,
86706, 86707, 86708, 86709, 86803, 86804, 87340, 87341, 87350, 87380), published in the Federal Register,
November 23, 2001, 66FR 58788, as part of the Negotiated Rulemaking for Clinical Diagnostic Laboratory
Services. Added CPT 87341 to LMRP. Added and deleted covered Diagnosis codes.
Reference:
http://www.empiremedicare.com/trainb/lmpb.htm
Electronic Submission of Medicare Claims to be Required
Effective October 16, 2003
The HIPAA Administrative Simplification Compliance Act (ASCA) prohibits the Department of Health and Human
Services (DHHS) from paying Medicare claims that are submitted on paper. It requires that all Medicare claims
be submitted electronically, unless certain waiver criteria are met.
DHHS will publish a regulation to implement this new authority. That regulation is expected to include
further detail to define the waiver criteria such as the circumstances when it would not be considered possible
to submit claims electronically, and other situations in which it may be permissible to submit a paper claim.
Medicare "waiver" for small providers billing on paper
Regulations for clarifying the exceptions are expected to be published soon along with instructions on the
"waiver" process. If you meet the small provider exception just continue to bill via paper. The term "small
provider of services or supplier" is being defined to mean:
- a physician, practitioner, facility, or supplier with fewer that 10 full-time equivalent employees and
- a provider of services with fewer than 25 full-time equivalent employees
To read the entire article go to:
http://www.cms.gov/hipaa/hipaa2/Smallproviderwaiverltr06-24-03.doc.
NHIC
Local Modifiers Eliminated
The Administrative Simplification provisions of HIPAA direct the federal government to adopt national
electronic standards for automated transfer of certain health care data between health care payers,
plans and providers. This will enable entire health care industry to communicate electronic data using
a single set of standards, thus eliminating all nonstandard formats currently in use.
As part of this process, NHIC has evaluated their local modifiers and made the decision to eliminate the
following modifiers, as of January 1, 2004:
Northern California
Northern California |
New Modifier |
Effective |
Y1 Reference Laboratory Charges (Non-Ownership) |
* |
Immediately** |
Y7 Outside or Reference Laboratory Charges (Ownership) |
* |
Immediately** |
* To identify clinical laboratory tests referred to another lab, independent clinical laboratories
(provider specialty 69 only) must use: Modifier - 90 Reference (Outside) Laboratory
** Changes have been made to provider enrollment files to capture the information for Northern
California previously reflected by use of the modifiers. Effective immediately, providers may cease billing
with the modifiers.
Reference: NHIC |